The booming molecular point-of-care (POC) diagnostics market is projected to reach $6.31 billion by 2033, driven by rising infectious disease prevalence and demand for rapid testing. Explore market trends, key players (Abbott, Roche, bioMérieux), and regional growth projections in this comprehensive analysis.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.